Does the media favor DLB or GEN?

In the previous week, Gen Digital had 3 more articles in the media than Dolby Laboratories. MarketBeat recorded 4 mentions for Gen Digital and 1 mentions for Dolby Laboratories. Gen Digital's average media sentiment score of 0.92 beat Dolby Laboratories' score of 0.49 indicating that Gen Digital is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dolby Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Gen Digital 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer DLB or RBRK?

In the previous week, Rubrik had 13 more articles in the media than Dolby Laboratories. MarketBeat recorded 14 mentions for Rubrik and 1 mentions for Dolby Laboratories. Rubrik's average media sentiment score of 0.51 beat Dolby Laboratories' score of 0.49 indicating that Rubrik is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dolby Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Rubrik 8 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor DLB or NTNX?

In the previous week, Nutanix had 10 more articles in the media than Dolby Laboratories. MarketBeat recorded 11 mentions for Nutanix and 1 mentions for Dolby Laboratories. Nutanix's average media sentiment score of 0.68 beat Dolby Laboratories' score of 0.49 indicating that Nutanix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dolby Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nutanix 3 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate DLB or NLOK?

Dolby Laboratories currently has a consensus target price of $87.50, indicating a potential upside of 49.67%. Given Dolby Laboratories' stronger consensus rating and higher possible upside, research analysts clearly believe Dolby Laboratories is more favorable than NortonLifeLock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dolby Laboratories 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 NortonLifeLock 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Dolby Laboratories (DLB) Competitors

$58.46 +1.13 (+1.97%)

Closing price 03:59 PM Eastern

Extended Trading

$58.40 -0.06 (-0.10%)

As of 07:30 PM Eastern

Compare

DLB vs. GEN, RBRK, NTNX, NLOK, and CHKP

Should you buy Dolby Laboratories stock or one of its competitors? Dolby Laboratories's main competitors and comparable companies include Gen Digital (GEN), Rubrik (RBRK), Nutanix (NTNX), NortonLifeLock (NLOK), and Check Point Software Technologies (CHKP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "systems software" industry.

How does Dolby Laboratories compare to Gen Digital?

Dolby Laboratories (NYSE:DLB) and Gen Digital (NASDAQ:GEN) are both technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

Dolby Laboratories currently has a consensus target price of $87.50, indicating a potential upside of 49.67%. Gen Digital has a consensus target price of $31.60, indicating a potential upside of 15.79%. Given Dolby Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Dolby Laboratories is more favorable than Gen Digital.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Gen Digital	0 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.38

Gen Digital has a net margin of 20.73% compared to Dolby Laboratories' net margin of 16.70%. Gen Digital's return on equity of 55.93% beat Dolby Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
Gen Digital	20.73%	55.93%	8.91%

58.6% of Dolby Laboratories shares are held by institutional investors. Comparatively, 81.4% of Gen Digital shares are held by institutional investors. 37.9% of Dolby Laboratories shares are held by company insiders. Comparatively, 9.7% of Gen Digital shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Gen Digital had 3 more articles in the media than Dolby Laboratories. MarketBeat recorded 4 mentions for Gen Digital and 1 mentions for Dolby Laboratories. Gen Digital's average media sentiment score of 0.92 beat Dolby Laboratories' score of 0.49 indicating that Gen Digital is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dolby Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Gen Digital	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Dolby Laboratories pays an annual dividend of $1.44 per share and has a dividend yield of 2.5%. Gen Digital pays an annual dividend of $0.50 per share and has a dividend yield of 1.8%. Dolby Laboratories pays out 61.3% of its earnings in the form of a dividend. Gen Digital pays out 29.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Dolby Laboratories has raised its dividend for 10 consecutive years. Dolby Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Dolby Laboratories has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, Gen Digital has a beta of 1.22, suggesting that its stock price is 22% more volatile than the broader market.

Gen Digital has higher revenue and earnings than Dolby Laboratories. Gen Digital is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.06	$255.02M	$2.35	24.88
Gen Digital	$5B	3.27	$973M	$1.72	15.87

Summary

Dolby Laboratories and Gen Digital tied by winning 10 of the 20 factors compared between the two stocks.

How does Dolby Laboratories compare to Rubrik?

Dolby Laboratories (NYSE:DLB) and Rubrik (NYSE:RBRK) are both technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

Dolby Laboratories has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, Rubrik has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market.

Dolby Laboratories has a net margin of 16.70% compared to Rubrik's net margin of -16.50%. Dolby Laboratories' return on equity of 11.08% beat Rubrik's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
Rubrik	-16.50%	N/A	-8.45%

Dolby Laboratories has higher revenue and earnings than Rubrik. Rubrik is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.06	$255.02M	$2.35	24.88
Rubrik	$1.32B	17.60	-$348.83M	-$1.26	N/A

Dolby Laboratories presently has a consensus target price of $87.50, suggesting a potential upside of 49.67%. Rubrik has a consensus target price of $113.31, suggesting a potential upside of 1.38%. Given Dolby Laboratories' higher probable upside, equities research analysts plainly believe Dolby Laboratories is more favorable than Rubrik.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Rubrik	1 Sell rating(s)	0 Hold rating(s)	28 Buy rating(s)	0 Strong Buy rating(s)	2.93

In the previous week, Rubrik had 13 more articles in the media than Dolby Laboratories. MarketBeat recorded 14 mentions for Rubrik and 1 mentions for Dolby Laboratories. Rubrik's average media sentiment score of 0.51 beat Dolby Laboratories' score of 0.49 indicating that Rubrik is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dolby Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Rubrik	8 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

58.6% of Dolby Laboratories shares are held by institutional investors. Comparatively, 49.5% of Rubrik shares are held by institutional investors. 37.9% of Dolby Laboratories shares are held by company insiders. Comparatively, 13.7% of Rubrik shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Dolby Laboratories beats Rubrik on 10 of the 16 factors compared between the two stocks.

How does Dolby Laboratories compare to Nutanix?

Dolby Laboratories (NYSE:DLB) and Nutanix (NASDAQ:NTNX) are both technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings.

58.6% of Dolby Laboratories shares are held by institutional investors. Comparatively, 85.3% of Nutanix shares are held by institutional investors. 37.9% of Dolby Laboratories shares are held by insiders. Comparatively, 2.4% of Nutanix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Dolby Laboratories has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market. Comparatively, Nutanix has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

In the previous week, Nutanix had 10 more articles in the media than Dolby Laboratories. MarketBeat recorded 11 mentions for Nutanix and 1 mentions for Dolby Laboratories. Nutanix's average media sentiment score of 0.68 beat Dolby Laboratories' score of 0.49 indicating that Nutanix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dolby Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nutanix	3 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nutanix has higher revenue and earnings than Dolby Laboratories. Nutanix is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.06	$255.02M	$2.35	24.88
Nutanix	$2.85B	6.56	$1.51B	$5.16	13.42

Nutanix has a net margin of 52.81% compared to Dolby Laboratories' net margin of 16.70%. Dolby Laboratories' return on equity of 11.08% beat Nutanix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
Nutanix	52.81%	-90.13%	9.09%

Dolby Laboratories currently has a consensus target price of $87.50, indicating a potential upside of 49.67%. Nutanix has a consensus target price of $72.71, indicating a potential upside of 5.00%. Given Dolby Laboratories' stronger consensus rating and higher probable upside, equities analysts plainly believe Dolby Laboratories is more favorable than Nutanix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Nutanix	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Nutanix beats Dolby Laboratories on 10 of the 16 factors compared between the two stocks.

How does Dolby Laboratories compare to NortonLifeLock?

Dolby Laboratories (NYSE:DLB) and NortonLifeLock (NASDAQ:NLOK) are both technology companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment.

Dolby Laboratories has a net margin of 16.70% compared to NortonLifeLock's net margin of 0.00%. Dolby Laboratories' return on equity of 11.08% beat NortonLifeLock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
NortonLifeLock	N/A	N/A	N/A

In the previous week, Dolby Laboratories had 1 more articles in the media than NortonLifeLock. MarketBeat recorded 1 mentions for Dolby Laboratories and 0 mentions for NortonLifeLock. Dolby Laboratories' average media sentiment score of 0.49 beat NortonLifeLock's score of 0.00 indicating that Dolby Laboratories is being referred to more favorably in the media.

Company	Overall Sentiment
Dolby Laboratories	Neutral
NortonLifeLock	Neutral

NortonLifeLock has higher revenue and earnings than Dolby Laboratories. NortonLifeLock is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.06	$255.02M	$2.35	24.88
NortonLifeLock	$2.82B	5.91	$817.05M	$1.43	20.38

Dolby Laboratories currently has a consensus target price of $87.50, indicating a potential upside of 49.67%. Given Dolby Laboratories' stronger consensus rating and higher possible upside, research analysts clearly believe Dolby Laboratories is more favorable than NortonLifeLock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
NortonLifeLock	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

58.6% of Dolby Laboratories shares are owned by institutional investors. Comparatively, 94.9% of NortonLifeLock shares are owned by institutional investors. 37.9% of Dolby Laboratories shares are owned by insiders. Comparatively, 3.3% of NortonLifeLock shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Dolby Laboratories has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, NortonLifeLock has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market.

Dolby Laboratories pays an annual dividend of $1.44 per share and has a dividend yield of 2.5%. NortonLifeLock pays an annual dividend of $0.50 per share and has a dividend yield of 1.7%. Dolby Laboratories pays out 61.3% of its earnings in the form of a dividend. NortonLifeLock pays out 35.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Dolby Laboratories has raised its dividend for 10 consecutive years. Dolby Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Dolby Laboratories beats NortonLifeLock on 14 of the 19 factors compared between the two stocks.

How does Dolby Laboratories compare to Check Point Software Technologies?

Check Point Software Technologies (NASDAQ:CHKP) and Dolby Laboratories (NYSE:DLB) are both technology companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

98.5% of Check Point Software Technologies shares are held by institutional investors. Comparatively, 58.6% of Dolby Laboratories shares are held by institutional investors. 29.0% of Check Point Software Technologies shares are held by company insiders. Comparatively, 37.9% of Dolby Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Check Point Software Technologies presently has a consensus target price of $148.74, indicating a potential upside of 8.47%. Dolby Laboratories has a consensus target price of $87.50, indicating a potential upside of 49.67%. Given Dolby Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Dolby Laboratories is more favorable than Check Point Software Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Check Point Software Technologies	0 Sell rating(s)	19 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.30
Dolby Laboratories	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

In the previous week, Check Point Software Technologies had 3 more articles in the media than Dolby Laboratories. MarketBeat recorded 4 mentions for Check Point Software Technologies and 1 mentions for Dolby Laboratories. Check Point Software Technologies' average media sentiment score of 0.70 beat Dolby Laboratories' score of 0.49 indicating that Check Point Software Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Check Point Software Technologies	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Dolby Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Check Point Software Technologies has a beta of 0.5, indicating that its stock price is 50% less volatile than the broader market. Comparatively, Dolby Laboratories has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

Check Point Software Technologies has higher revenue and earnings than Dolby Laboratories. Check Point Software Technologies is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Check Point Software Technologies	$2.73B	5.14	$1.06B	$9.77	14.04
Dolby Laboratories	$1.35B	4.06	$255.02M	$2.35	24.88

Check Point Software Technologies has a net margin of 37.93% compared to Dolby Laboratories' net margin of 16.70%. Check Point Software Technologies' return on equity of 38.80% beat Dolby Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Check Point Software Technologies	37.93%	38.80%	15.60%
Dolby Laboratories	16.70%	11.08%	9.04%

Summary

Check Point Software Technologies beats Dolby Laboratories on 11 of the 16 factors compared between the two stocks.

Get Dolby Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DLB vs. The Competition

Export

Metric	Dolby Laboratories	Software Industry	Technology Sector	NYSE Exchange
Market Cap	$5.37B	$15.96B	$31.10B	$23.14B
Dividend Yield	2.51%	3.41%	2.75%	3.62%
P/E Ratio	24.88	141.74	78.73	28.40
Price / Sales	4.06	1,287.31	591.59	21.42
Price / Cash	13.43	46.92	49.35	39.12
Price / Book	2.12	8.82	8.02	4.71
Net Income	$255.02M	$433.53M	$702.98M	$1.07B
7 Day Performance	-3.19%	1.06%	2.83%	-0.05%
1 Month Performance	-10.28%	-1.37%	-1.26%	-3.43%
1 Year Performance	-19.31%	-1.62%	177.32%	8.44%

Dolby Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
DLB Dolby Laboratories	4.5747 of 5 stars	$58.46 +2.0%	$87.50 +49.7%	-20.2%	$5.37B	$1.35B	24.88	2,051
GEN Gen Digital	4.6327 of 5 stars	$31.41 +3.8%	$31.60 +0.6%	+0.6%	$18.80B	$5.08B	18.26	3,900
RBRK Rubrik	2.1092 of 5 stars	$100.13 +15.6%	$113.31 +13.2%	+40.4%	$17.96B	$1.32B	N/A	3,797
NTNX Nutanix	4.0604 of 5 stars	$67.69 +2.7%	$72.71 +7.4%	-9.1%	$17.82B	$2.85B	13.12	7,800
NLOK NortonLifeLock	N/A	$30.26 +1.0%	N/A	+0.1%	$17.29B	$2.82B	21.16	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:DLB) was last updated on 9/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dolby Laboratories (DLB) Competitors

DLB vs. GEN, RBRK, NTNX, NLOK, and CHKP

How does Dolby Laboratories compare to Gen Digital?

Summary

How does Dolby Laboratories compare to Rubrik?

Summary

How does Dolby Laboratories compare to Nutanix?

Summary

How does Dolby Laboratories compare to NortonLifeLock?

Summary

How does Dolby Laboratories compare to Check Point Software Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DLB vs. The Competition

Dolby Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dolby Laboratories (DLB) Competitors

DLB vs. GEN, RBRK, NTNX, NLOK, and CHKP

How does Dolby Laboratories compare to Gen Digital?

Do analysts rate DLB or GEN?

Is DLB or GEN more profitable?

Do insiders & institutionals believe in DLB or GEN?

Does the media favor DLB or GEN?

Is DLB or GEN a better dividend stock?

Which has more volatility and risk, DLB or GEN?

Which has better earnings and valuation, DLB or GEN?

Summary

How does Dolby Laboratories compare to Rubrik?

Which has more volatility and risk, DLB or RBRK?

Is DLB or RBRK more profitable?

Which has stronger valuation & earnings, DLB or RBRK?

Do analysts rate DLB or RBRK?

Does the media prefer DLB or RBRK?

Do insiders and institutionals hold more shares of DLB or RBRK?

Summary

How does Dolby Laboratories compare to Nutanix?

Do institutionals and insiders have more ownership in DLB or NTNX?

Which has more volatility & risk, DLB or NTNX?

Does the media favor DLB or NTNX?

Which has preferable valuation and earnings, DLB or NTNX?

Is DLB or NTNX more profitable?

Do analysts prefer DLB or NTNX?

Summary

How does Dolby Laboratories compare to NortonLifeLock?

Is DLB or NLOK more profitable?

Does the media refer more to DLB or NLOK?

Which has stronger valuation & earnings, DLB or NLOK?

Do analysts rate DLB or NLOK?

Do institutionals and insiders hold more shares of DLB or NLOK?

Which has more volatility & risk, DLB or NLOK?

Is DLB or NLOK a better dividend stock?

Summary

How does Dolby Laboratories compare to Check Point Software Technologies?

Do insiders & institutionals believe in CHKP or DLB?

Do analysts prefer CHKP or DLB?

Does the media favor CHKP or DLB?

Which has more risk & volatility, CHKP or DLB?

Which has preferable earnings & valuation, CHKP or DLB?

Is CHKP or DLB more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DLB vs. The Competition

Dolby Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools